key: cord-0708228-acjifzti
authors: Hainque, Elodie
title: Rapid worsening in Parkinson's disease may hide COVID-19 infection
date: 2020-05-08
journal: Parkinsonism Relat Disord
DOI: 10.1016/j.parkreldis.2020.05.008
sha: e46f0daafe9247a643caea2aa154dd74b3bff576
doc_id: 708228
cord_uid: acjifzti

nan

COVID 19 is global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) 1 . Patients with COVID-19 usually present with fever, pain, respiratory illness and sometimes digestive symptoms. Older age is one of the risk factor associated with more severe form of COVID-19 that may cause acute respiratory distress syndrom (ARDS) and death 2 . Parkinson's disease (PD) is a common neurodegenerative whose prevalence is increasing with age 3 . Currently, there is no information regarding COVID-19 presentation, course and outcome in patients with PD 4 . In addition, in order to limit SARS-Cov-2 diffusion, many countries took drastic measures such as complete lock-down that were associated with dramatic changes in PD patients' routines and life style 5 . Here we report on two patients with PD treated by subthalamic deep brain stimulation (STN-DBS) that develop COVID-19 with misleading presentations and poor outcome. Those two cases illustrate that early and accurate diagnosis of COVID-19 in PD patients may be challenging. COVID-19 may mimic PD evolution triggered by usual causes of worsening such as battery's end-of-life or by deleterious effects of the lockdown (increased psychological stress or reduced physical activity) 5 . In addition, COVID-19 symptoms such as fatigue, anosmia, hot flush or painful limbs also belong to the spectrum of non-motor PD signs 6 . Finally, this study draws attention to the potential severity of COVID-19 in PD and highlights the need of larger studies to assess the exact prevalence and fatality rate of COVID-19 in PD population.

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Clinical course and risk factors for mortality of adult inpatients with COVID 19 in Wuhan, China: a retrospective cohort study

The Prevalence of Parkinson's Disease: A Systematic Review and Meta-Analysis

SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration

The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities

Non-motor Symptoms of Parkinson's Disease

Dopaminergic Pathophysiology and Treatment